Stock 1093 CSPC PHARMACEUTICAL GROUP LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages CSPC Pharmaceutical Group Ltd.

Equities

1093

HK1093012172

Delayed Hong Kong S.E.
Other stock markets
 11:17:08 2024-07-02 pm EDT 		5-day change 1st Jan Change
6.2 HKD -0.80% Intraday chart for CSPC Pharmaceutical Group Ltd. -5.34% -14.60%
Jul. 02 China Grants CSPC Pharmaceutical Group Conditional Marketing Approval for Anti-Tumor Injection MT
Jun. 28 CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval CI

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval
CSPC Pharma's Breast Cancer Drug Gets Approval in China
CSPC Pharmaceutical Group Limited Announces Palbociclib Tablets Obtains Drug Registration Approval
Chassez la convoitise, elle revient au galop
En Direct des Marchés : calice jusqu'à la lie pour Atos ? Volkswagen s'allie à Rivian et spéculation sur DoorDash
Borsa di Italia: Scacciare l'avidità e tornare indietro
Bolsa de Madrid: Conduce fuera la codicia y vuelve corriendo
China approves CSPC Pharma mRNA cancer therapy for clinical trials
CSPC Pharmaceutical Gets Go-Ahead for Clinical Trial of Multiple Myeloma Drug in China
CSPC Pharmaceutical Group Limited Obtains Approval from National Medical Products Administration of the People's Republic of China to Conduct Clinical Trials in China
CSPC Pharmaceutical Group Limited commences an Equity Buyback for 1,189,609,173 shares, representing 10% of its issued share capital, under the authorization approved on May 28, 2024.
CSPC Pharmaceutical Buys Back Further Shares
CSPC Pharmaceutical Repurchases 7 Million Shares
CSPC Pharmaceutical Trustee Repurchases Further Shares Under Award Scheme
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
CSPC Pharmaceutical’s Trustee Buys Back Further Shares
CSPC Pharmaceutical Group Limited Receives Approval for Olaparib Tablets by the National Medical Products Administration of the People's Republic of China
CSPC Pharmaceutical Repurchases 3 Million Shares
CSPC Pharmaceutical Group Limited Announces Board Changes
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 1093 Stock
  4. News CSPC Pharmaceutical Group Ltd.
  5. Other languages